| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| MediciNova Inc. | MN-001 | Nonalcoholic steatohepatitis (NASH) | Phase 2 | oral | Gastroenterology | |
| Medicus Pharma Ltd. | Doxorubicin - (SKNJCT-003) | Non-invasively treat basal cell carcinoma (BCC) | Phase 2 | Ongoing | Intravenous | Oncology |
| Medicus Pharma Ltd. | SKNJCT-004 | Basal Cell Carcinoma (BCC) | Phase 2 | Enrollment Initiation | Intravenous | Oncology |
| MediWound Ltd. | EscharEx - (VALUE) | Venous leg ulcers (VLU’s) | Phase 3 | Ongoing | Topical | Wound Care |
| MediWound Ltd. | EscharEx | Lower leg ulcers | Phase 2 | Ongoing | Topical | Wound Care |
| MediWound Ltd. | EscharEx | Lower leg ulcers | Phase 2 | Ongoing | Topical | Wound Care |
| Medtronic plc. | ASCEND | Sinus Balloon | Phase 3 | oral | #N/A | |
| Medtronic plc. | SINUVA - ENCORE | Nasal polyps | Phase 3 | nasal | Respiratory |